MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
Eloxx Pharmaceuticals, Inc. (ELOX)
Eloxx Pharmaceuticals, Inc. (ELOX)
source: myfinsight.com
Download
Download image
Proceeds from issuance of
pre-funded warrants under...
$6,991K
Exercise of stock options
$40K
Net cash provided by
(used in) financing...
$7,031K
Increase in cash, cash
equivalents and restricted...
$1,578K
Canceled cashflow
$5,453K
Accounts payable
$315K
Stock-based compensation
$46K
Accrued interest
-$21K
Amortization of debt discount
$7K
Net cash (used in)
provided by operating...
-$5,453K
Canceled cashflow
$389K
Net loss
-$3,754K
Prepaid expenses and
other current assets
$1,655K
Accrued expenses
-$377K
Gain on
extinguishment of accrued...
$56K
Back